Aleglitazar, a dual PPAR-α/γ agonist, combines the lipid benefits of fibrates and the insulin-sensitizing benefits of thiazolidinediones.  To investigate the pharmacokinetic effects of co-administration of atorvastatin or rosuvastatin with aleglitazar.